CorporateB2B2C

EIPICO

Egyptian pharma since 1980

Egypt 10th of Ramadan City Founded 1980 1001-5000 Website
Operating Since1980 (46y)
Total Awarded$755KSee the contracts
Contract Awards7
Award Year2019

About EIPICO

EIPICO (Egyptian International Pharmaceutical Industries Company) is one of Egypt's largest pharmaceutical manufacturers, founded in 1980 in 10th of Ramadan City. The company produces hundreds of pharmaceutical products including antibiotics, cardiovascular drugs, and generic medicines, and exports to over 50 countries worldwide.

Contract Awards

7 public contracts recorded as awarded to EIPICO, worth $755K in total.

Source for every entry below: World Bank Contract Awards Dataset (DS00005)

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$109K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115749-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs$111K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115768-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Purchase of hepatitis c drugs$108K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115728-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$106K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115193

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115789-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115231

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115180

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Is this you?

Claiming starts a review. A member of staff reads it, and nothing on this profile changes until they decide.

Claim this business
Report an error

Contact

eipico.com.eg

Quick Facts

CountryEgypt
Founded1980
TypeCorporate
ModelB2B2C
Team size1001-5000
Operating in
EgyptSaudi ArabiaSudanYemenIraqLibya

Other Corporate profiles in Egypt

See all
Corporate
Faragalla GroupEgyptian beverages since 1956
Alexandria
Corporate
Heinz Egypt (Kraft Heinz)Egyptian tomato processing
Cairo
Corporate
Beltone FinancialEgyptian financial services
Cairo
Corporate
CI Capital HoldingEgyptian investment banking
Cairo
Corporate
Misr InsuranceEgyptian insurance since 1934
Cairo
Corporate
Rotana EgyptArab music and media in Egypt
Cairo